APRE logo

Aprea Therapeutics, Inc.

APRE
Healthcare|Biotechnology|US
$0.52
+0.02 (+4.50%)
DCF Value
$2.14
Tangible Book / Share
$0.64
Cash / Share
$0.71
Next Earnings Report
Mar 15, 2027
EPS est. -$0.10 · Revenue est. $368.5K
Financing Filings (last 12 months)
8
Shelf registrations / offering prospectuses — latest May 15, 2026 (424B7). Possible dilution.

Upcoming Data Readouts (1)

Jun 2027
Est. completion
P1Advanced Solid Tumor
Study of APR-1051 in Patients With Advanced Solid Tumors
NCT06260514n=90

Recent Press Releases

Aprea Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
Nov 5, 2026 · GlobeNewsWire
Aprea Therapeutics Announces Third Quarter 2026 Financial Results
Nov 4, 2026 · GlobeNewsWire
Aprea Therapeutics to Host Pre-ESMO Virtual Panel on the State of WEE1 Inhibition in Precision Oncology
Oct 16, 2026 · GlobeNewsWire
Aprea Therapeutics to Present at October Conferences
Oct 5, 2026 · GlobeNewsWire
Aprea Therapeutics to Present Updated Interim Phase 1 Data on WEE1 Inhibitor APR-1051 in an Oral Presentation at 38th EORTC-NCI-AACR Symposium
Sep 22, 2026 · GlobeNewsWire
Aprea Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
Sep 10, 2026 · GlobeNewsWire
Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs
Aug 28, 2026 · GlobeNewsWire
Aprea Therapeutics Announces Second Quarter 2026 Financial Results
Aug 12, 2026 · GlobeNewsWire

SEC Filings (69)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 4, 202610-QQuarterly reportDocumentIndex
Nov 4, 20268-KMaterial eventDocumentIndex
Aug 28, 20268-KMaterial eventDocumentIndex
Aug 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 12, 202610-QQuarterly reportDocumentIndex
Aug 12, 20268-KMaterial eventDocumentIndex
Jul 23, 20268-KMaterial eventDocumentIndex
Jun 17, 20268-KMaterial eventDocumentIndex
May 15, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 15, 2026424B7Offering prospectusDocumentIndex
May 13, 202610-QQuarterly reportDocumentIndex
May 13, 20268-KMaterial eventDocumentIndex
Apr 30, 2026ARSAnnual report to holdersDocumentIndex
Apr 30, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 30, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 29, 2026EFFECTDocumentIndex
Apr 29, 2026424B3Offering prospectusDocumentIndex
Apr 27, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Apr 22, 2026S-3Shelf registrationDocumentIndex
Apr 20, 2026PRE 14AProxy / shareholder voteDocumentIndex
Apr 7, 2026SC 13GPassive 5%+ stakeDocumentIndex
Apr 1, 2026SC 13GPassive 5%+ stakeDocumentIndex
Apr 1, 20268-KMaterial eventDocumentIndex
Mar 30, 20268-KMaterial eventDocumentIndex
Mar 19, 2026EFFECTDocumentIndex
Mar 19, 2026424B3Offering prospectusDocumentIndex
Mar 17, 2026S-3/AShelf registrationDocumentIndex
Mar 16, 2026S-8Employee stock planDocumentIndex
Mar 16, 202610-KAnnual reportDocumentIndex
Mar 16, 20268-KMaterial eventDocumentIndex
Feb 20, 2026S-3Shelf registrationDocumentIndex
Feb 18, 20268-KMaterial eventDocumentIndex
Feb 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jan 29, 20268-KMaterial eventDocumentIndex
Jan 28, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jan 23, 20268-KMaterial eventDocumentIndex
Jan 9, 20268-KMaterial eventDocumentIndex
Dec 30, 2025424B3Offering prospectusDocumentIndex
Dec 29, 2025EFFECTDocumentIndex
Dec 29, 2025DDocumentIndex